- Previous Close
881.50 - Open
875.05 - Bid --
- Ask --
- Day's Range
860.00 - 916.00 - 52 Week Range
788.50 - 1,529.90 - Volume
27,192 - Avg. Volume
32,976 - Market Cap (intraday)
20.252B - Beta (5Y Monthly) 0.09
- PE Ratio (TTM)
115.53 - EPS (TTM)
7.49 - Earnings Date --
- Forward Dividend & Yield 2.00 (0.23%)
- Ex-Dividend Date Sep 6, 2024
- 1y Target Est
1,162.25
Tatva Chintan Pharma Chem Limited engages in manufacture and sale of specialty chemicals in India and internationally. It offers a portfolio of structure directing agents for zeolites synthesis; phase transfer catalysts; electrolyte salts for super capacitor and zinc ion batteries; and pharmaceutical and agrochemical products, and other specialty chemicals in the form of intermediates, disinfectants, catalysts, and solvents. The company serves automotive, refinery, pharmaceutical, agro-chemicals, paints and coatings, dyes and pigments, personal care, and flavor and fragrances industries. Tatva Chintan Pharma Chem Limited was incorporated in 1996 and is headquartered in Vadodara, India.
www.tatvachintan.com689
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: TATVA.NS
View MorePerformance Overview: TATVA.NS
Trailing total returns as of 1/9/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: TATVA.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: TATVA.NS
View MoreValuation Measures
Market Cap
20.30B
Enterprise Value
20.30B
Trailing P/E
115.69
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.50
Price/Book (mrq)
2.74
Enterprise Value/Revenue
5.51
Enterprise Value/EBITDA
39.26
Financial Highlights
Profitability and Income Statement
Profit Margin
4.74%
Return on Assets (ttm)
1.49%
Return on Equity (ttm)
2.40%
Revenue (ttm)
3.71B
Net Income Avi to Common (ttm)
176.14M
Diluted EPS (ttm)
7.49
Balance Sheet and Cash Flow
Total Cash (mrq)
148.73M
Total Debt/Equity (mrq)
2.07%
Levered Free Cash Flow (ttm)
-842.32M